Veracyte Ownership | Who Owns Veracyte?


OverviewForecastRevenueFinancialsChartTranscripts

Veracyte Ownership Summary


Veracyte is owned by 28.13% institutional investors, 0.52% insiders, and 71.35% retail investors. Blackrock funding, inc. /de is the largest institutional shareholder, holding 16.76% of VCYT shares. iShares Core S&P Small-Cap ETF is the top mutual fund, with 6.04% of its assets in Veracyte shares.

VCYT Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockVeracyte28.13%0.52%71.35%
SectorHealthcare Stocks 35.58%11.87%52.55%
IndustryBiotech Stocks 35.75%11.83%52.41%

Institutional Shareholders


Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Blackrock funding, inc. /de13.17M16.76%$424.29M
Vanguard group8.50M10.80%$358.02M
Blackrock7.79M10.42%$168.88M
Fmr7.76M9.88%$250.07M
Artisan partners limited partnership5.50M6.99%$177.04M
State street5.04M6.42%$162.45M
Ark investment management3.05M3.89%$98.36M
Dimensional fund advisors lp2.88M3.67%$92.79M
Wellington management group llp2.56M3.26%$82.40M
First trust advisors lp2.12M2.69%$68.19M

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Iron triangle partners lp485.00K2.37%$16.65M
Perkins capital management75.33K2.27%$2.43M
Palisades investment partners170.60K2.15%$5.50M
Summit creek advisors225.89K1.49%$7.28M
Arrowmark colorado1.37M1.18%$44.26M
Efg asset management (north america)219.98K0.98%$7.56M
Oberweis asset management inc/839.83K0.80%$27.05M
Ark investment management3.05M0.76%$98.36M
Casdin capital276.31K0.67%$8.90M
Granite investment partners298.59K0.59%$9.62M

Top Buyers

HolderShares% AssetsChange
Fmr7.76M0.01%2.03M
First trust advisors lp2.12M0.05%833.54K
State street5.04M0.01%682.68K
Blackrock7.79M0.00%581.69K
Vanguard fiduciary trust548.17K0.00%548.17K

Top Sellers

HolderShares% AssetsChange
Ark investment management3.05M0.76%-833.73K
Artisan partners limited partnership5.50M0.28%-766.67K
Driehaus capital management---631.71K
Fiera capital---625.54K
Eventide asset management---570.72K

New Positions

HolderShares% AssetsChangeValue
Vanguard fiduciary trust548.17K0.00%548.17K$17.66M
Iron triangle partners lp485.00K2.37%485.00K$16.65M
Norges bank225.60K0.00%225.60K$8.93M
Amundi161.74K0.00%161.74K$5.83M
Arrowstreet capital, limited partnership141.81K0.00%141.81K$4.57M

Sold Out

HolderChange
Newedge advisors-2.00
Strategic advocates-2.00
Cedar mountain advisors-3.00
Global financial private client-5.00
Kohmann bosshard financial services-6.00

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Mar 31, 2026165-50.45%22,106,368-74.49%280.23%85-51.70%57-49.56%
Dec 31, 2025226-24.16%56,376,420-37.19%710.54%121-27.11%77-11.49%
Sep 30, 20252835.99%88,589,4967.86%1131.03%16121.97%83-15.31%
Jun 30, 2025273-5.21%85,426,3961.00%1090.93%1381.47%98-8.41%
Mar 31, 20259-97.20%3,530,599-95.70%40.04%5-96.84%3-97.41%

Top Mutual Funds Shareholders


HolderShares% HoldingChange
iShares Core S&P Small-Cap ETF4.82M6.04%1.08K
Vanguard US Total Market Shares ETF2.46M3.16%2.69K
Vanguard Total Stock Mkt Idx Inv2.52M3.16%8.55K
First Trust NYSE Arca Biotech ETF2.42M3.03%-11.28K
State Street® SPDR® S&P® Biotech ETF2.18M2.74%-21.60K
iShares Russell 2000 ETF1.84M2.31%15.56K
Vanguard Small Cap Index1.83M2.30%-2.68K
ARK Disruptive Innovation Full Composite1.82M2.29%-652.06K
Vanguard Explorer Inv1.77M2.22%162.00K
ARK Innovation ETF1.76M2.21%-128.50K

Recent Insider Transactions


DateNameRoleActivityValue
May 22, 2026Wygant Jonathan VP, Chief Accounting OfficerSell$1.09M
May 20, 2026EPSTEIN ROBERT S-Sell$440.13K
May 06, 2026McGuire Annie SVP, General CounselSell$204.08K
May 06, 2026McGuire Annie SVP, General CounselSell$194.13K
Mar 04, 2026Chambers Rebecca Chief Financial OfficerSell$506.46K

Insider Transactions Trends


DateBuySell
2026 Q2-3
2026 Q1-8
2025 Q4-32
2025 Q3-2
2025 Q2-3

VCYT Ownership FAQ


Who Owns Veracyte?

Veracyte shareholders are primarily institutional investors at 28.13%, followed by 0.52% insiders and 71.35% retail investors. The average institutional ownership in Veracyte's industry, Biotech Stocks , is 35.75%, which Veracyte falls below.

Who owns the most shares of Veracyte?

Veracyte’s largest shareholders are Blackrock funding, inc. /de (13.17M shares, 16.76%), Vanguard group (8.5M shares, 10.80%), and Blackrock (7.79M shares, 10.42%). Together, they hold 37.99% of Veracyte’s total shares outstanding.

Does Blackrock own Veracyte?

Yes, BlackRock owns 10.42% of Veracyte, totaling 7.79M shares as of Jun 2024. This represents 0.00% of BlackRock's total assets, with a market value of 168.88M$. In the last quarter, BlackRock increased its holdings by 581.69K shares, a 8.07% change.

Who is Veracyte’s biggest shareholder by percentage of total assets invested?

Iron triangle partners lp is Veracyte’s biggest shareholder by percentage of total assets invested, with 2.37% of its assets in 485K Veracyte shares, valued at 16.65M$.

Who is the top mutual fund holder of Veracyte shares?

iShares Core S&P Small-Cap ETF is the top mutual fund holder of Veracyte shares, with 6.04% of its total shares outstanding invested in 4.82M Veracyte shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools